Hepatocyte Growth Factor Releases Mink Epithelial Cells from Transforming Growth Factor β1-Induced Growth Arrest by Restoring Cdk6 Expression and Cyclin E-Associated Cdk2 Activity

REFERENCES

• Akiyama, T., T. Ohuchi, S. Sumida, K. Matsumoto, and J. Toyoshima 1992. Phosphorylation of the retinoblastoma protein by Cdk2. Proc. Natl. Acad. Sci. USA 89:7900–7904.
   PubMed Web of Science ®Google Scholar
• Birchmeier, C., and J. Birchmeier 1993. Molecular aspects of mesenchymal-epithelial interactions. Annu. Rev. Cell Biol. 9:511–540.
   PubMedGoogle Scholar
• Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Bussolino, F., M. F. Di Renzo, M. Ziche, E. Bocchietto, M. Olivero, L. Naldini, G. Gaudino, L. Tamagnone, A. Coffer, and J. Comoglio 1992. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119:629–641.
   PubMed Web of Science ®Google Scholar
• Connell-Crowley, L., J. W. Harper, and J. Goodrich 1997. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8:287–301.
   PubMed Web of Science ®Google Scholar
• Cover, C. M., S. J. Hsieh, S. H. Tran, G. Hallden, G. S. Kim, L. F. Bjeldanes, and J. Firestone 1998. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J. Biol. Chem. 273:3838–3847.
   PubMed Web of Science ®Google Scholar
• Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and J. Wang 1995. Transforming growth factor-β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92:5545–5549.
   PubMed Web of Science ®Google Scholar
• de Caestecker, M. P., W. T. Parks, C. J. Frank, P. Castagnino, D. P. Bottaro, A. B. Roberts, and J. Lechleider 1998. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev. 12:1587–1592.
   PubMed Web of Science ®Google Scholar
• Dulic, V., E. Lees, and J. Reed 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958–1961.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and J. Livingston 1993. TGF-β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009–1020.
   PubMed Web of Science ®Google Scholar
• Gabrielli, B. G., M. S. Lee, D. H. Walker, H. Piwnica-Worms, and J. Maller 1992. Cdc25 regulates the phosphorylation and activity of the Xenopus Cdk2 protein kinase complex. J. Biol. Chem. 267:18040–18046.
   PubMedGoogle Scholar
• Graña, X., and J. Reddy 1995. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11:211–219.
   PubMed Web of Science ®Google Scholar
• Gu, Y., J. Rosenblatt, and J. Morgan 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11:3995–4005.
   PubMed Web of Science ®Google Scholar
• Haapajärvi, T., L. Kivinen, K. Pitkänen, and J. Laiho 1995. Cell cycle dependent effects of U.V.-radiation on p53 expression and retinoblastoma protein phosphorylation. Oncogene 11:151–159.
   PubMedGoogle Scholar
• Hall, M., S. Bates, and J. Peters 1995. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11:1581–1588.
   PubMed Web of Science ®Google Scholar
• Hannon, G. J., and J. Beach 1994. p15ink4b is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257–261.
   PubMed Web of Science ®Google Scholar
• Herrera, R. E., V. P. Sah, B. O. Williams, T. P. Mäkelä, R. A. Weinberg, and J. Jacks 1996. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:2402–2407.
   PubMedGoogle Scholar
• Iavarone, A., and J. Massagué 1997. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387:417–422.
   PubMedGoogle Scholar
• Jeffrey, P. D., A. A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massagué, and J. Pavletich 1995. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376:313–320.
   PubMed Web of Science ®Google Scholar
• Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and J. Sherr 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331–342.
   PubMed Web of Science ®Google Scholar
• Kingsley, D. M. 1994. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:133–146.
   PubMed Web of Science ®Google Scholar
• Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massagué 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260:536–539.
   PubMed Web of Science ®Google Scholar
• Kretzschmar, M., J. Doody, and J. Massagué 1997. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389:618–622.
   PubMed Web of Science ®Google Scholar
• Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massagué 1990. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185.
   PubMed Web of Science ®Google Scholar
• Li, C. Y., L. Suardet, and J. Little 1995. Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J. Biol. Chem. 270:4971–4974.
   PubMed Web of Science ®Google Scholar
• Lundberg, A. S., and J. Weinberg 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753–761.
   PubMed Web of Science ®Google Scholar
• Mal, A., R. Y. C. Poon, P. H. Howe, H. Toyoshima, T. Hunter, and J. Harter 1996. Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFβ-treated cells. Nature 380:262–265.
   PubMedGoogle Scholar
• Massagué, J. 1996. TGF-β signaling: receptors, transducers, and Mad proteins. Cell 85:947–950.
   PubMed Web of Science ®Google Scholar
• Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Kato 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066–2076.
   PubMed Web of Science ®Google Scholar
• Millar, J. B., C. H. McGowan, G. Lenaers, R. Jones, and J. Russell 1991. p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast. EMBO J. 10:4301–4309.
   PubMed Web of Science ®Google Scholar
• Montesano, R., K. Matsumoto, T. Nakamura, and J. Orci 1991. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67:901–908.
   PubMed Web of Science ®Google Scholar
• Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131–134.
   PubMed Web of Science ®Google Scholar
• Müller, D., C. Bouchard, B. Rudolph, P. Steiner, I. Stuckmann, R. Saffrich, W. Ansorge, W. Huttner, and J. Eilers 1997. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin/Cdk2 complexes. Oncogene 15:2561–2576.
   PubMed Web of Science ®Google Scholar
• Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, D. Y. Loh, and J. Nakayama 1996. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707–720.
   PubMed Web of Science ®Google Scholar
• Ohtsubo, M., and J. Roberts 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908–1912.
   PubMed Web of Science ®Google Scholar
• Perez-Roger, I., D. L. Solomon, A. Sewing, and J. Land 1997. Myc activation of cyclin/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes. Oncogene 14:2373–2381.
   PubMed Web of Science ®Google Scholar
• Pines, J. 1995. Cyclins and cyclin-dependent kinases: theme and variations. Adv. Cancer Res. 66:181–212.
   PubMedGoogle Scholar
• Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massagué, J. M. Roberts, and J. Koff 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9–22.
   PubMed Web of Science ®Google Scholar
• Polyak, K., M. H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massagué 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66.
   PubMed Web of Science ®Google Scholar
• Reynisdóttir, I., and J. Massagué 1997. The subcellular locations of p15Ink4b and p27Kip1 coordinate their inhibitory interactions with Cdk4 and Cdk2. Genes Dev. 11:492–503.
   PubMed Web of Science ®Google Scholar
• Reynisdóttir, I., K. Polyak, A. Iavarone, and J. Massagué 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831–1845.
   PubMed Web of Science ®Google Scholar
• Russo, A. A., P. D. Jeffrey, A. K. Patten, J. Massagué, and J. Pavletich 1996. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382:325–331.
   PubMed Web of Science ®Google Scholar
• Sandhu, C., J. Garbe, N. Bhattacharya, J. Daksis, C.-H. Pan, P. Yaswen, J. Koh, J. M. Slingerland, and J. Stampfer 1997. Transforming growth factor β stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol. Cell. Biol. 17:2458–2467.
   PubMedGoogle Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672–1677.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551–555.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. Roberts 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149–1163.
   PubMed Web of Science ®Google Scholar
• Slingerland, J. M., L. Hengst, C. H. Pan, D. Alexander, M. R. Stampfer, and J. Reed 1994. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14:3683–3694.
   PubMed Web of Science ®Google Scholar
• Solomon, M. J., T. Lee, and J. Kirschner 1992. Role of phosphorylation in p34cdc2 activation: identification of an activating kinase. Mol. Biol. Cell 3:13–27.
   PubMed Web of Science ®Google Scholar
• Taipale, J., and J. Keski-Oja 1996. Hepatocyte growth factor releases epithelial and endothelial cells from growth arrest induced by transforming growth factor-β1. J. Biol. Chem. 271:4342–4348.
   PubMedGoogle Scholar
• Taipale, J., J. Saharinen, and J. Keski-Oja 1998. Extracellular matrix associated transforming growth factor-β: role in cancer cell growth and invasion. Adv. Cancer Res. 75:87–133.
   PubMed Web of Science ®Google Scholar
• van den Eijnden-van Raaij, A. J., I. Koornneef, and J. van Zoelen 1988. A new method for high yield purification of type β transforming growth factor from human platelets. Biochem. Biophys. Res. Commun. 157:16–23.
   PubMedGoogle Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• Zarkowska, T., and J. Mittnacht 1997. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272:12738–12746.
   PubMed Web of Science ®Google Scholar
• Zerfass-Thome, K., W. Zwerschke, B. Mannhardt, R. Tindle, J. W. Botz, and J. Jansen-Dürr 1996. Inactivation of the Cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13:2323–2330.
   PubMed Web of Science ®Google Scholar
• Zhu, L., E. Harlow, and J. Dynlacht 1995. p107 uses a p21Cip1-related domain to bind cyclin/Cdk2 and regulate interactions with E2F. Genes Dev. 9:1740–1752.
   PubMed Web of Science ®Google Scholar